Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A morphometric signature to identify ductal carcinoma in situ with a low risk of progression.
Sobral-Leite M, Castillo SP, Vonk S, Messal HA, Melillo X, Lam N, de Bruijn B, Hagos YB, van den Bos M, Sanders J, Almekinders M, Visser LL, Groen EJ, Kristel P, Ercan C, Azarang L, van Rheenen J, Hwang ES, Yuan Y; Grand Challenge PRECISION Consortium; Menezes R, Lips EH, Wesseling J. Sobral-Leite M, et al. Among authors: groen ej. NPJ Precis Oncol. 2025 Jan 28;9(1):25. doi: 10.1038/s41698-024-00769-6. NPJ Precis Oncol. 2025. PMID: 39875514 Free PMC article.
Application of deep learning on mammographies to discriminate between low and high-risk DCIS for patient participation in active surveillance trials.
Alaeikhanehshir S, Voets MM, van Duijnhoven FH, Lips EH, Groen EJ, van Oirsouw MCJ, Hwang SE, Lo JY, Wesseling J, Mann RM, Teuwen J; Grand Challenge PRECISION Consortium Steering Group. Alaeikhanehshir S, et al. Among authors: groen ej. Cancer Imaging. 2024 Apr 5;24(1):48. doi: 10.1186/s40644-024-00691-x. Cancer Imaging. 2024. PMID: 38576031 Free PMC article.
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS.
Visser LL, Elshof LE, Van de Vijver K, Groen EJ, Almekinders MM, Sanders J, Bierman C, Peters D, Hofland I, Broeks A, van Leeuwen FE, Rutgers EJT, Schmidt MK, Schaapveld M, Lips EH, Wesseling J. Visser LL, et al. Among authors: groen ej. Am J Surg Pathol. 2019 Nov;43(11):1574-1582. doi: 10.1097/PAS.0000000000001306. Am J Surg Pathol. 2019. PMID: 31206365
Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study.
Mannu GS, Groen EJ, Wang Z, Schaapveld M, Lips EH, Chung M, Joore I, van Leeuwen FE, Teertstra HJ, Winter-Warnars GAO, Darby SC, Wesseling J. Mannu GS, et al. Among authors: groen ej. Breast Cancer Res Treat. 2019 Nov;178(2):409-418. doi: 10.1007/s10549-019-05362-1. Epub 2019 Aug 6. Breast Cancer Res Treat. 2019. PMID: 31388937 Free PMC article.
Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study.
Groen EJ, Hudecek J, Mulder L, van Seijen M, Almekinders MM, Alexov S, Kovács A, Ryska A, Varga Z, Andreu Navarro FJ, Bianchi S, Vreuls W, Balslev E, Boot MV, Kulka J, Chmielik E, Barbé E, de Rooij MJ, Vos W, Farkas A, Leeuwis-Fedorovich NE, Regitnig P, Westenend PJ, Kooreman LFS, Quinn C, Floris G, Cserni G, van Diest PJ, Lips EH, Schaapveld M, Wesseling J; Grand Challenge PRECISION consortium. Groen EJ, et al. Breast Cancer Res Treat. 2020 Oct;183(3):759-770. doi: 10.1007/s10549-020-05816-x. Epub 2020 Jul 30. Breast Cancer Res Treat. 2020. PMID: 32734520 Free PMC article.
89 results